These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 19618764

  • 1. Vaccine failures and vaccine effectiveness in children during measles outbreaks in New South Wales, March-May 2006.
    Sheppeard V, Forssman B, Ferson MJ, Moreira C, Campbell-Lloyd S, Dwyer DE, McAnulty JM.
    Commun Dis Intell Q Rep; 2009 Mar; 33(1):21-6. PubMed ID: 19618764
    [Abstract] [Full Text] [Related]

  • 2. Increased measles-mumps-rubella (MMR) vaccine uptake in the context of a targeted immunisation campaign during a measles outbreak in a vaccine-reluctant community in England.
    Le Menach A, Boxall N, Amirthalingam G, Maddock L, Balasegaram S, Mindlin M.
    Vaccine; 2014 Feb 26; 32(10):1147-52. PubMed ID: 24440207
    [Abstract] [Full Text] [Related]

  • 3. Measles transmission and vaccine effectiveness during a large outbreak on a densely populated island: implications for vaccination policy.
    Marin M, Nguyen HQ, Langidrik JR, Edwards R, Briand K, Papania MJ, Seward JF, LeBaron CW.
    Clin Infect Dis; 2006 Feb 01; 42(3):315-9. PubMed ID: 16392073
    [Abstract] [Full Text] [Related]

  • 4. Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England.
    Cohen C, White JM, Savage EJ, Glynn JR, Choi Y, Andrews N, Brown D, Ramsay ME.
    Emerg Infect Dis; 2007 Jan 01; 13(1):12-7. PubMed ID: 17370510
    [Abstract] [Full Text] [Related]

  • 5. Outbreak of measles in primary school students with high first dose MMR vaccination coverage.
    Ong G, Rasidah N, Wan S, Cutter J.
    Singapore Med J; 2007 Jul 01; 48(7):656-61. PubMed ID: 17609829
    [Abstract] [Full Text] [Related]

  • 6. Self-collected buccal swabs and rapid, real-time PCR during a large measles outbreak in Wales: Evidence for the protective effect of prior MMR immunisation.
    Moore C, Cottrell S, Hoffmann J, Carr M, Evans H, Dunford L, Lawson H, Brown KE, Jones R.
    J Clin Virol; 2015 Jun 01; 67():1-7. PubMed ID: 25959148
    [Abstract] [Full Text] [Related]

  • 7. MMR vaccine effectiveness in an outbreak that involved day-care and primary schools.
    Barrabeig I, Rovira A, Muñoz P, Batalla J, Rius C, Sánchez JA, Domínguez À.
    Vaccine; 2011 Oct 19; 29(45):8024-31. PubMed ID: 21893145
    [Abstract] [Full Text] [Related]

  • 8. Effectiveness of Rubella vaccine in a rubella outbreak in Guangzhou city, China, 2014.
    Chang C, Mo X, Hu P, Liang W, Ma H, An Z, Liu J, Zheng H.
    Vaccine; 2015 Jun 22; 33(28):3223-7. PubMed ID: 25989448
    [Abstract] [Full Text] [Related]

  • 9. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.
    Vesikari T, Baer M, Willems P.
    Pediatr Infect Dis J; 2007 Feb 22; 26(2):153-8. PubMed ID: 17259879
    [Abstract] [Full Text] [Related]

  • 10. Detection of serum antibodies against measles, mumps and rubella after primary measles, mumps and rubella (MMR) vaccination in children.
    Rafiei Tabatabaei S, Esteghamati AR, Shiva F, Fallah F, Radmanesh R, Abdinia B, Shamshiri AR, Khairkhah M, Shekari Ebrahimabad H, Karimi A.
    Arch Iran Med; 2013 Jan 22; 16(1):38-41. PubMed ID: 23273235
    [Abstract] [Full Text] [Related]

  • 11. Measles outbreak in western Sydney. Vaccine failure or failure to vaccinate?
    McDonnell LF, Jorm LR, Patel MS.
    Med J Aust; 1995 May 01; 162(9):471-5. PubMed ID: 7746203
    [Abstract] [Full Text] [Related]

  • 12. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H, Heinonen OP, Valle M, Paunio M, Virtanen M, Karanko V, Cantell K.
    N Engl J Med; 1994 Nov 24; 331(21):1397-402. PubMed ID: 7969278
    [Abstract] [Full Text] [Related]

  • 13. A serological survey of measles, mumps and rubella immunity among school aged children in Western Saudi Arabia.
    Jaber SM.
    Saudi Med J; 2006 Jan 24; 27(1):63-9. PubMed ID: 16432596
    [Abstract] [Full Text] [Related]

  • 14. MMR vaccination and disease elimination: the Finnish experience.
    Davidkin I, Kontio M, Paunio M, Peltola H.
    Expert Rev Vaccines; 2010 Sep 24; 9(9):1045-53. PubMed ID: 20822347
    [Abstract] [Full Text] [Related]

  • 15. [Mumps epidemic in vaccinated children in West Switzerland].
    Ströhle A, Eggenberger K, Steiner CA, Matter L, Germann D.
    Schweiz Med Wochenschr; 1997 Jun 28; 127(26):1124-33. PubMed ID: 9312835
    [Abstract] [Full Text] [Related]

  • 16. Safety and immunogenicity of a measles-mumps-rubella-varicella vaccine given as a second dose in children up to six years of age.
    Halperin SA, Ferrera G, Scheifele D, Predy G, Stella G, Cuccia M, Douha M, Willems P.
    Vaccine; 2009 May 05; 27(20):2701-6. PubMed ID: 19428882
    [Abstract] [Full Text] [Related]

  • 17. Immunogenicity and safety of measles-mumps-rubella-varicella (MMRV) vaccine followed by one dose of varicella vaccine in children aged 15 months-2 years or 2-6 years primed with measles-mumps-rubella (MMR) vaccine.
    Gillet Y, Steri GC, Behre U, Arsène JP, Lanse X, Helm K, Esposito S, Meister N, Desole MG, Douha M, Willems P.
    Vaccine; 2009 Jan 14; 27(3):446-53. PubMed ID: 19007835
    [Abstract] [Full Text] [Related]

  • 18. The epidemiology of rubella in England and Wales before and after the 1994 measles and rubella vaccination campaign: fourth joint report from the PHLS and the National Congenital Rubella Surveillance Programme.
    Miller E, Waight P, Gay N, Ramsay M, Vurdien J, Morgan-Capner P, Hesketh L, Brown D, Tookey P, Peckham C.
    Commun Dis Rep CDR Rev; 1997 Feb 07; 7(2):R26-32. PubMed ID: 9046126
    [Abstract] [Full Text] [Related]

  • 19. Previous vaccination modifies both the clinical disease and immunological features in children with measles.
    Mitchell P, Turner N, Jennings L, Dong H.
    J Prim Health Care; 2013 Jun 01; 5(2):93-8. PubMed ID: 23748389
    [Abstract] [Full Text] [Related]

  • 20. Measles, mumps and rubella infections and atopic disorders in MMR-unvaccinated and MMR-vaccinated children.
    Bernsen RM, van der Wouden JC.
    Pediatr Allergy Immunol; 2008 Sep 01; 19(6):544-51. PubMed ID: 18266826
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.